Jiangsu Hengrui Medicine Co., Ltd. (HKG:1276)
Hong Kong · Delayed Price · Currency is HKD 82.05
+2.75 (3.47%)
At close: Aug 15, 2025, 4:00 PM HKT
Jiangsu Hengrui Medicine Market Cap
Jiangsu Hengrui Medicine has a market cap or net worth of 461.51 billion as of August 15, 2025. Its market cap has increased by 59.97% in one year.
Market Cap
461.51B
Enterprise Value
435.88B
Revenue
31.30B
Ranking
n/a
PE Ratio
62.92
Stock Price
82.05
Market Cap Chart
Since October 20, 2000, Jiangsu Hengrui Medicine's market cap has increased from 2.43B to 461.51B, an increase of 18,915.26%. That is a compound annual growth rate of 23.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 461.51B | 48.59% |
| Dec 31, 2024 | 310.59B | -1.97% |
| Dec 29, 2023 | 316.84B | 14.05% |
| Dec 30, 2022 | 277.81B | -29.95% |
| Dec 31, 2021 | 396.57B | -43.57% |
| Dec 31, 2020 | 702.75B | 62.99% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 248.84B |
| Hansoh Pharmaceutical Group Company | 226.30B |
| JD Health International | 179.05B |
| Innovent Biologics | 162.71B |
| Akeso | 141.46B |
| Sino Biopharmaceutical | 137.89B |
| WuXi Biologics | 125.37B |
| CSPC Pharmaceutical Group | 122.56B |